Exosomes are nano-sized vesicles secreted by cells. According to scientific literature, exosomes can regulate inflammatory responses, promote angiogenesis and neural repair, activate cells, and support tissue regeneration. Studies also suggest that stem cell-derived exosomes hold significant potential for clinical applications, positioning them as a promising emerging product in the regenerative medicine market with the potential to address currently unmet medical needs.
GWOXI ensures the quality of exosome production by rigorously selecting cell sources and employing proprietary patented technology to stimulate high-yield exosome secretion enriched with bioactive substances. The exosomes undergo professional isolation and purification, aseptic filling in clinical-grade environments, and comprehensive testing for bioactivity and quality. These tests include Nanoparticle Tracking Analysis (NTA), biomarker profiling, protein concentration measurement, growth factor quantification, source cell quality identification, and sterility testing. All processes are designed to meet the gold standards of exosome characterization, helping accelerate your exosome product development and research applications.
✅ Manufactured to High-Quality Clinical Standards
✅ Rigorous purification techniques and testing procedures
✅ We support delivery tailored to a variety of application requirements.
✅ 提Providing a comprehensive one-stop production solution(One-Stop Service)
✅ Certified to meet international standards for cosmetic ingredients.(INCI Name)
1. Inquiry
Assess requirements and expected applications to offer guidance on cell sourcing and production yield planning.
2. Provide standard pricing proposals or formalize the engagement through contract agreements.
The parties finalize specifications and delivery terms, followed by signing the partnership agreement.
3. Culturing and Exosome Collection
Cells are prepared and expanded in culture following designated specifications.
4. Exosome Purification and Analytical Testing
Perform purification and concentration procedures, along with comprehensive quality assessments.
5. Deliver products along with comprehensive testing reports.
Products are delivered per client specifications, with testing reports included.
For more information on partnership opportunities or pricing plans, kindly contact us.
Exosomes demonstrate tremendous potential in cellular communication and regulation of biological activity. In particular, stem cell-derived exosomes have become a focal point in regenerative medicine and the biotech industry.
However, with the explosive growth of related products in the market, we must raise an important question:Are you really using genuine exosomes?
Purification TechnologyPurification technology is the core key to ensuring exosome quality. Since cell culture supernatants contain a variety of particles of different sizes and functions—such as cell debris, proteins, and other extracellular vesicles—only through rigorous purification processes can genuine exosomes be effectively isolated while preserving their integrity and functionality.
At presentPublished by the International Society for Extracellular Vesicles《MISEV2023》Aiming to provide detailed guidelines for the purification and analysis of exosome research:
Even with highly efficient purification techniques, it is impossible to guarantee the consistent isolation of pure exosomes every time. At this point,Identification TechniquesThey become essential tools for confirming the authenticity of purified exosome products.
Only through rigorous purification and precise identification techniques can the quality and safety of exosomes be ensured. For clinical-grade exosomes, in addition to meeting clinical standards, the source of clinical-grade cells is equally critical, along with identification methods that confirm exosome characteristics and functionality.
Exosome Purification and Analytical Techniques: Guidelines Based on MISEV2023
GWOXI stem cells possess an exclusive exosome technology platform. In addition to having a cell bank and manufacturing facilities that meet clinical-grade standards, we provide comprehensive safety and functional testing of exosomes to ensure the purity and stability of exosome products, fully meeting clients’ contract manufacturing needs.
Feeling weak knees during outings? Experiencing numbness in your hands or feet after staying in the same position too long? Is your sleep quality worsening as you age? Noticing fine lines under your eyes and dull skin tone, with a growing sense of fatigue?
These signs indicate that our bodies are aging. Maintaining health and slowing down aging are goals we all aspire to. With advances in medical technology and skincare, delaying aging is no longer an unattainable dream! Recently, exosomes have become a rising star in the field of anti-aging.
Exosomes are an emerging medical technology making waves in clinical medicine, aesthetics, cosmetics, and even anti-aging research. But what exactly are exosomes? How did they rise from obscurity to become a new choice in the medical field? This article will take you on a journey to explore the true value of exosomes.
The following summarizes the exosome research guidelines based on the International Society for Extracellular Vesicles’ (ISEV) MISEV2023 recommendations.
(Further Understanding:Exosome Purification and Analysis Techniques According to MISEV2023 Recommendations)
Among the many sources of exosomes, mesenchymal stem cell-derived exosomes have emerged as a promising new option for disease treatment and regenerative medicine, thanks to their natural repair and regenerative capabilities, as well as their low immunogenicity.
Exosomes have multiple sources, and those derived from carefully reviewed stem cell sources, combined with rigorous clinical preparation standards and supporting documentation, undergo thorough verification. Only after such validation can stem cell-derived exosomes ensure both safety and efficacy, making them a promising new option for clinical medical treatments.
References
INCI Name is International Nomenclature Cosmetic Ingredients (INCI).This refers to the International Nomenclature of Cosmetic Ingredients (INCI), which has established a standardized naming system for cosmetic ingredients since its founding in 1973. The naming system is developed by the International Nomenclature Committee (INC) and published by the Personal Care Products Council (PCPC) in the "International Cosmetic Ingredient Dictionary and Handbook." It serves as a trusted resource for the cosmetics industry and scientists, and further helps protect consumer rights.
Currently, several biotechnology companies worldwide have had their stem cell-derived exosomes approved and certified through the INCI Name review. It is important to note, however, that the manufacturing processes of these exosomes differ to some extent between companies. Before market launch, the products must undergo safety evaluations and comply with local cosmetic registration and regulatory requirements. According to the literature, stem cell-derived exosomes possess various potential benefits, including promoting wound healing and skin regeneration, alleviating inflammation, and stimulating hair growth. Consumers must first understand the source of exosomes and other factors that may influence their effectiveness, such as species (human, plant, animal), cell source (tissue, extract), manufacturing conditions, patented processes, experimental data, test reports, and third-party verification. Additionally, the concentration of exosomes can affect their therapeutic effects. Therefore, when selecting related products, consumers should pay attention to this information to better safeguard their rights.
In March 2025, GWOXI stem cell-derived exosomes obtained INCI Name certification as "Human Adipose-derived Mesenchymal Stem Cell Exosomes." This designation provides a clearer confirmation of their purity and efficacy, compared to the general term "Extracellular Vesicles." Additionally, GWOXI's stem cell sources meet clinical standards, with exosomes secreted by adipose-derived mesenchymal stem cells, which comply with international ICH guidelines. These exosomes can be used not only in cosmetic products but also in the development of new clinical drugs, representing pharmaceutical-grade raw materials. The certification from the Personal Care Products Council (PCPC) under the INCI Name system marks the first step toward international recognition of the raw material, confirming its safety and effectiveness. This milestone will help expand the market and serve as a significant growth driver for upcoming orders in GWOXI's CDMO division.